Morris, Valerie (2014) Idelalisib Effectively Treats Indolent Lymphoma. Science Spotlight, 4 (3).
Preview |
Text
Idelalisib Effectively Treats Indolent Lymphoma.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (302kB) | Preview |
Article URL: http://www.nejm.org/doi/full/10.1056/NEJMoa1314583
| Item Type: | Article or Abstract |
|---|---|
| Additional Information: | Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, Flinn IW, Flowers CR, Martin P, Viardot A,Blum KA, Goy AH, Davies AJ, Zinzani PL, Dreyling M, Johnson D, Miller LL, Holes L, Li D, Dansey RD, Godfrey WR, Salles GA. 2014. PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma. N Engl J Med. Epub ahead of print, doi: 10.1056/NEJMoa1314583. See also: Furman, R.R., Sharman, J.P., Coutre, S.E., Cheson, B.D., Pagel, J.M., Hillmen, P., Barrientos, J.C., Zelenetz, A.D., Kipps, T.J., Flinn, I., Ghia, P., Eradat, H., Ervin, T., Lamanna, N., Coiffier, B., Pettitt, A.R., Ma, S., Stilgenbauer, S., Cramer, P., Aiello, M., Johnson, D.M., Miller, L.L., Li, D., Jahn, T.M., Dansey, R.D., Hallek, M., O'Brien, S.M. 2014. Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med. Epub ahead of publication, doi: 10.1056/NEJMoa1315226. |
| Collections: | Science Spotlight |
| Depositing User: | Users 60 not found. |
| Date Deposited: | 19 Mar 2015 19:13 |
| Last Modified: | 19 Mar 2015 19:13 |
| URI: | http://authors.fhcrc.org/id/eprint/685 |
Repository Administrators Only
 |
View Item |
